Response to Lo et al

Am J Gastroenterol. 2017 Feb;112(2):387-388. doi: 10.1038/ajg.2016.577.

Authors

Yi-Wen Huang^{1

2

3

4}, An-Chi Hsieh¹, Sien-Sing Yang^{1

5}

Affiliations

¹ Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.
² School of Medicine, Taipei Medical University College of Medicine, Taipei, Taiwan.
³ Division of Gastroenterology, Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
⁴ School of Medicine, China Medical University, Taichung, Taiwan.
⁵ School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan.

PMID: 28154385
DOI: 10.1038/ajg.2016.577

No abstract available

Publication types

Comment

MeSH terms

Hepatitis B, Chronic*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Liver Cirrhosis
Risk

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors